Literature DB >> 27748624

Tafamidis in hereditary ATTR amyloidosis - our experience on monitoring the ocular manifestations.

Inês Casal1, Sílvia Monteiro1, João Melo Beirão1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27748624     DOI: 10.1080/13506129.2016.1236332

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  5 in total

Review 1.  Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives.

Authors:  João Heitor Marques; João Coelho; Maria João Menéres; João Melo Beirão
Journal:  Clin Ophthalmol       Date:  2022-07-09

2.  Ocular Manifestations in a Chinese Pedigree of Familial Amyloidotic Polyneuropathy Carrying the Transthyretin Mutation c.401A>G (p.Tyr134Cys).

Authors:  Xiaonan Zhuang; Zhongcui Sun; Fengjuan Gao; Min Wang; Wenyi Tang; Wei Liu; Keyan Wang; Jihong Wu; Rui Jiang; Gezhi Xu
Journal:  Genes (Basel)       Date:  2022-05-16       Impact factor: 4.141

3.  Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors.

Authors:  Erica Irene Uneus; Christer Wilhelmsson; David Bäckström; Intissar Anan; Jonas Wixner; Björn Pilebro; Katrine Riklund; Mattias Ögren; Margareta Ögreen; Jan Axelsson; Ole B Suhr; Torbjörn Sundström
Journal:  Front Neurol       Date:  2022-03-04       Impact factor: 4.003

4.  Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage.

Authors:  Junhui Shen; Hao Yu; Jijian Lin; Li Zhang; Xiaohong Pan; Zhiqing Chen
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

5.  Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis.

Authors:  Bokyung Kim; Young Ho Ko; Massimiliano Runfola; Simona Rapposelli; Gabriella Ortore; Grazia Chiellini; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.